CN Patent

CN103429239A — 增加网织红细胞血红蛋白含量的方法

Assigned to Fibrogen Inc · Expires 2013-12-04 · 12y expired

What this patent protects

本发明涉及用于治疗血红蛋白生成不足的方法及化合物。提供了有用于增加网织红细胞血红蛋白含量的方法及化合物。

USPTO Abstract

本发明涉及用于治疗血红蛋白生成不足的方法及化合物。提供了有用于增加网织红细胞血红蛋白含量的方法及化合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN103429239A
Jurisdiction
CN
Classification
—
Expires
2013-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Fibrogen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.